SEC Filing Summary: Ra Medical Systems, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. on November 13, 2018. The filing serves as a current report to announce the company's financial results for the quarter ended September 30, 2018. The registrant is incorporated in Delaware and maintains its principal executive offices in Carlsbad, California. The company is designated as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that these results were announced via a press release and a conference call held on the filing date. Detailed financial data is contained in the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are incorporated by reference but not reproduced in the body of this 8-K.
Material Changes
No specific material changes in financial condition or operations are detailed within the text of this filing. The report indicates that the company issued a press release regarding its quarterly results, but the specific variances versus the prior comparable period are not listed in the provided text.
Guidance, Outlook, and Risks
- Management Commentary: The company held a conference call on November 13, 2018, to discuss the financial results.
- Regulation FD Disclosure: An investor presentation (Exhibit 99.2) was furnished under Regulation FD and is available on the company's investor relations website.
- Legal Status of Information: The information in Item 2.02 and the attached exhibits is being "furnished" and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information shall not be incorporated by reference into any registration statement unless expressly stated otherwise.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended September 30, 2018.
- Access Exhibit 99.2 (Investor Presentation) for management's outlook, guidance, and strategic updates.
- Verify the company's status as an emerging growth company and any associated accounting transition periods.
- Confirm that the financial data in the press release has been audited or reviewed, as the 8-K itself does not contain the financial statements.